arrow_back Back to App

Marihuana and CBD Research Expansion: New Rules and Access

This act simplifies scientific research on marihuana and cannabidiol (CBD), potentially accelerating drug development. It modifies registration rules for researchers and manufacturers, ensuring better access to these substances for medical purposes. Citizens can anticipate more research into the potential medical uses of marihuana and CBD.
Key points
Streamlining the process for researchers and institutions to obtain approval for marihuana research.
Increasing the availability of marihuana and CBD for research and the production of FDA-approved drugs.
Physicians can freely discuss the potential benefits and harms of marihuana and its derivatives with patients (or their guardians).
The federal government will conduct and coordinate research on the effects of marihuana and CBD on health, including on adolescent brains and cognitive abilities.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_253
Sponsor: Sen. Feinstein, Dianne [D-CA]
Process start date: 2021-02-04
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Cannabidiol and Marihuana Research Expansion Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_253.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-02-04.

What are the main provisions?

Key points include:

  • Streamlining the process for researchers and institutions to obtain approval for marihuana research.
  • Increasing the availability of marihuana and CBD for research and the production of FDA-approved drugs.
  • Physicians can freely discuss the potential benefits and harms of marihuana and its derivatives with patients (or their guardians).
  • The federal government will conduct and coordinate research on the effects of marihuana and CBD on health, including on adolescent brains and cognitive abilities.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Feinstein, Dianne [D-CA].

What is the latest detailed status?

The latest detailed status is: Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S1781-1783)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-02.

CATEGORIES

Health Courts and Law